1. Home
  2. AMSC vs FOLD Comparison

AMSC vs FOLD Comparison

Compare AMSC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMSC
  • FOLD
  • Stock Information
  • Founded
  • AMSC 1987
  • FOLD 2002
  • Country
  • AMSC United States
  • FOLD United States
  • Employees
  • AMSC N/A
  • FOLD N/A
  • Industry
  • AMSC Metal Fabrications
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMSC Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • AMSC Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • AMSC 2.7B
  • FOLD 2.5B
  • IPO Year
  • AMSC 1991
  • FOLD 2007
  • Fundamental
  • Price
  • AMSC $57.86
  • FOLD $8.86
  • Analyst Decision
  • AMSC Buy
  • FOLD Strong Buy
  • Analyst Count
  • AMSC 1
  • FOLD 8
  • Target Price
  • AMSC $39.00
  • FOLD $27.88
  • AVG Volume (30 Days)
  • AMSC 1.1M
  • FOLD 5.1M
  • Earning Date
  • AMSC 10-29-2025
  • FOLD 11-04-2025
  • Dividend Yield
  • AMSC N/A
  • FOLD N/A
  • EPS Growth
  • AMSC N/A
  • FOLD N/A
  • EPS
  • AMSC 0.39
  • FOLD N/A
  • Revenue
  • AMSC $254,886,000.00
  • FOLD $571,160,000.00
  • Revenue This Year
  • AMSC $28.23
  • FOLD $21.12
  • Revenue Next Year
  • AMSC $11.78
  • FOLD $21.23
  • P/E Ratio
  • AMSC $146.59
  • FOLD N/A
  • Revenue Growth
  • AMSC 63.73
  • FOLD 25.35
  • 52 Week Low
  • AMSC $13.98
  • FOLD $5.51
  • 52 Week High
  • AMSC $70.49
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • AMSC 48.32
  • FOLD 63.71
  • Support Level
  • AMSC $52.75
  • FOLD $8.33
  • Resistance Level
  • AMSC $61.94
  • FOLD $8.62
  • Average True Range (ATR)
  • AMSC 4.93
  • FOLD 0.30
  • MACD
  • AMSC -0.70
  • FOLD 0.04
  • Stochastic Oscillator
  • AMSC 28.81
  • FOLD 81.82

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: